Regulus Therapeutics Inc. buy Quitte
Start price
28.06.16
/
50%
€290.08
Target price
28.07.16
€389.66
Performance (%)
36.01%
End price
28.07.16
€394.54
Summary
This prediction ended on 28.07.16 with a price of €394.54. The BUY prediction by Quitte for Regulus Therapeutics Inc. saw massive gains of 36.01%. Quitte has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Regulus Therapeutics Inc. | 6.767% | 6.767% | 17.355% | -73.208% |
| iShares Core DAX® | 3.054% | -1.396% | 15.789% | 12.675% |
| iShares Nasdaq 100 | 4.389% | -5.391% | 29.906% | 39.325% |
| iShares Nikkei 225® | 5.386% | -3.105% | 16.065% | 8.150% |
| iShares S&P 500 | 2.955% | -3.011% | 25.903% | 37.650% |
Comments by Quitte for this prediction
In the thread Regulus Therapeutics Inc. diskutieren
Quitte stimmt dem Sentiment von 'Buy' zu
Regulus Therapeutics Inc.'s stock lost more than half of its value Monday after federal regulators gave the drug maker notice that its experimental treatment for chronic hepatitis C had been placed on a clinical hold.
Read more: http://www.nasdaq.com/article/us-hot-stocks-hot-stocks-to-watch-20160628-00597#ixzz4CtJUijsB